Dallas COVID-19 Treatment
Monoclonal Antibody Infusions
At Advance ER, we are keeping close tabs on the novel coronavirus to keep our community and patients protected. We are ensuring this safety by offering monoclonal antibody infusions for those who are eligible. The Federal Drug Administration has granted emergency use authorization for Bamlanivimab. This treatment is given through an IV and may take up to an hour to administer. However, the total treatment time is approximately 3 hours, and this includes check-in time and monitoring for side effects.
What Is Monoclonal Antibody Therapy?
Monoclonal antibody therapy is an investigational medicine used for the treatment of COVID-19 in non-hospitalized adults and who are at high risk for developing severe coronavirus symptoms. Monoclonal antibodies are given by infusions can help in quicker recovery, as well as helping protect your overall health.
Am I A Candidate for Treatment?
Treatment is proven effective in reducing symptoms of COVID-19 and boosting your immune system to respond more quickly to the virus. Our providers at Advance ER will ensure you are eligible for treatment before any administration.
You may be a candidate for monoclonal antibody infusion if you are:
- 65 years of age or older
55 years of age or older with:
- Cardiovascular Disease
- High Blood Pressure
- Chronic Respiratory Diseases
Any age with the following symptoms:
- Type 1 or 2 Diabetes
- Weakened Immune System
- Kidney Disease
Your child may be a candidate for monoclonal antibody infusion if they are:
12 – 17 years of age and at least 88 pounds with:
- Sickle Cell Disease
- Asthma/Respiratory Issues
- Regularly uses a ventilator or feeding tube
- Cerebral palsy
ER Services in Dallas
If you find yourself struggling with common symptoms relating to COVID-19, you must seek emergency help right away. The emergency care professionals at Advance ER provide specialized treatments for patients in Dallas, TX, and the surrounding areas.